Literature DB >> 14667531

A simple method for the rapid purification of copia virus-like particles from Drosophila Schneider 2 cells.

André S Bachmann1, Gloria Corpuz, Wade P Hareld, Gordon Wang, Beth Ann Coller.   

Abstract

Drosophila retrotransposon copia produces virus-like particles (VLPs) in cultured Drosophila cells. The VLPs contain copia RNA and reverse transcriptase activity, and thus, play a major role in copia replication. Here, we report a rapid and simple method for the purification of copia VLPs from Drosophila Schneider 2 (S2) cells. The VLP purification procedure consists of a series of short centrifugation steps and eliminates the tedious and time-consuming performance of sucrose, metrizamide and cesium chloride (CsCl) gradients. The purity and presence of VLPs at different purification steps was monitored by transmission electron microscopy (TEM), immunochemical detection methods, and by Northern blot analysis. In addition to providing a fast protocol for VLP purification, our results also show that copia particles are mainly located in the nucleus of S2 cells. This new protocol may find broad applications for the purification of various other VLPs, and thus, may be of great value to other investigators with similar interests.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14667531     DOI: 10.1016/j.jviromet.2003.09.025

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  8 in total

1.  Formulation of a protein-free medium based on IPL-41 for the sustained growth of Drosophila melanogaster S2 cells.

Authors:  Fabiana R X Batista; Carlos A Pereira; Ronaldo Z Mendonça; Angela M Moraes
Journal:  Cytotechnology       Date:  2008-06-17       Impact factor: 2.058

2.  Growth of recombinant Drosophila melanogaster Schneider 2 cells producing rabies virus glycoprotein in bioreactor employing serum-free medium.

Authors:  Adriana L L Galesi; Marcelo A Aguiar; Renato M Astray; Elisabeth F P Augusto; Angela M Moraes
Journal:  Cytotechnology       Date:  2008-03-02       Impact factor: 2.058

3.  Kinetic response of a Drosophila melanogaster cell line to different medium formulations and culture conditions.

Authors:  R Bovo; A L L Galesi; S A C Jorge; R A M Piccoli; A M Moraes; C A Pereira; E F P Augusto
Journal:  Cytotechnology       Date:  2008-04-17       Impact factor: 2.058

4.  Arabidopsis retrotransposon virus-like particles and their regulation by epigenetically activated small RNA.

Authors:  Seung Cho Lee; Evan Ernst; Benjamin Berube; Filipe Borges; Jean-Sebastien Parent; Paul Ledon; Andrea Schorn; Robert A Martienssen
Journal:  Genome Res       Date:  2020-04-17       Impact factor: 9.043

5.  Purification of Bionanoparticles.

Authors:  L Pedro; S S Soares; G N M Ferreira
Journal:  Chem Eng Technol       Date:  2008-05-27       Impact factor: 1.728

Review 6.  Large-scale production and purification of VLP-based vaccines.

Authors:  Tiago Vicente; António Roldão; Cristina Peixoto; Manuel J T Carrondo; Paula M Alves
Journal:  J Invertebr Pathol       Date:  2011-07       Impact factor: 2.841

Review 7.  N-glycosylation modification of plant-derived virus-like particles: an application in vaccines.

Authors:  Hyun-Soon Kim; Jae-Heung Jeon; Kyung Jin Lee; Kisung Ko
Journal:  Biomed Res Int       Date:  2014-05-25       Impact factor: 3.411

8.  Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells.

Authors:  Jing Jin; Richard D Tarrant; Emma J Bolam; Philip Angell-Manning; Max Soegaard; David J Pattinson; Pawan Dulal; Sarah E Silk; Jennifer M Marshall; Rebecca A Dabbs; Fay L Nugent; Jordan R Barrett; Kathryn A Hjerrild; Lars Poulsen; Thomas Jørgensen; Tanja Brenner; Ioana N Baleanu; Helena M Parracho; Abdessamad Tahiri-Alaoui; Gary Whale; Sarah Moyle; Ruth O Payne; Angela M Minassian; Matthew K Higgins; Frank J Detmers; Alison M Lawrie; Alexander D Douglas; Robert Smith; Willem A de Jongh; Eleanor Berrie; Rebecca Ashfield; Simon J Draper
Journal:  NPJ Vaccines       Date:  2018-08-17       Impact factor: 7.344

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.